GEN - Genetic Engineering and Biotechnology News

Advancing the Manufacture of Patient Accessible Cell and Gene Therapies at Place-of-Care

Officials at Caring Cross emphasize that the organization is dedicated to ensuring the global affordability of advanced therapies.
Fierce Pharma

UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai

Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a ...

Cell and Gene Therapy Manufacturing Market to Reach USD 146.2 Billion by 2032 Amid Rising Demand for Personalized Therapies, Viral Vector Capacity, and Automated Bioprocessing ...

The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...
GEN - Genetic Engineering and Biotechnology News

Eveo Cell Therapy Platform Launched by Sartorius to Address Structural Manufacturing Bottlenecks

Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.

Lineage Cell (LCTX) Launches Its Latest Cell Therapy Program

Lineage Cell Therapeutics Inc. (NYSE:LCTX) is one of the 10 best penny stocks that could triple your money. On March 24, ...
Seeking Alpha

Lineage Cell Therapeutics outlines manufacturing milestone and anticipates OpRegen 36-month data update while advancing OPC1 clinical plans

Management continues to anticipate the presentation of three-year OpRegen trial data in June 2025, with Culley expressing hope it will “provide additional conviction in our approach.” There remains no ...